[1] |
Benson AB, D'Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4):302-310.
|
[2] |
王刚,张龙辉,张长坤,等.不同手术方式治疗早期胆囊癌的临床疗效比较[J].中国普外基础与临床杂志,2017, 24(10):1220-1225.
|
[3] |
Aldossary MY, Alayed AA, Amr SS, et al. Gallbladder cancer in Eastern Province of Saudi Arabia: a retrospective cohort study[J]. Ann Med Surg, 2018(35):117-123.
|
[4] |
Pitt SC, Jin LX, Hall BL, et al. Incidental gallbladder cancer at cholecystectomy: when should the surgeon be suspicious?[J]. Ann Surg, 2014, 260(1):128-133.
|
[5] |
Qadan M, Kingham TP. Technical aspects of gallbladder cancer surgery[J]. Surg Clin North Am, 2016, 96(2):229-245.
|
[6] |
Kanthan R, Senger JL, Ahmed S, et al. Gallbladder cancer in the 21st century[J]. J Oncol, 2015:967472.
|
[7] |
Xu WY, Zhang HH, Yang XB, et al. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients[J]. World J Gastroenterol, 2018, 24(13):1451-1463.
|
[8] |
Wang YF, Feng FL, Zhao XH, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer[J]. World J Gastroenterol, 2014, 20(14):4085-4092.
|
[9] |
Aloreidi K, Zamulko A. Elevated vitamin B12: a rare presentation for gallbladder adenocarcinoma[J]. S D Med, 2018, 71(4):171-173.
|
[10] |
Patkar S, Shinde RS, Kurunkar SR, et al. Radiological diagnosis alone risks overtreatment of benign disease in suspected gallbladder cancer: a word of caution in an era of radical surgery[J]. Indian J Cancer, 2017, 54(4):681-684.
|
[11] |
Nitta T, Kataoka J, Ohta M, et al. Surgical strategy for suspected early gallbladder carcinoma including incidental gallbladder carcinoma diagnosed during or after cholecystectomy[J]. Ann Med Surg, 2018(33):56-59.
|
[12] |
Tayeb M, Rauf F, Ahmad K, et al. Is it necessary to submit grossly normal looking gall bladder specimens for histopathological examination?[J]. Asian Pac J Cancer Prev, 2015, 16(4):1535-1538.
|
[13] |
Koppatz H, Nordin A, Scheinin T, et al. The risk of incidental gallbladder cancer is negligible in macroscopically normal cholecystectomy specimens[J]. HPB, 2018, 20(5):456-461.
|
[14] |
耿智敏,汤朝晖.2018年NCCN指南更新版胆囊癌诊治进展述评[J].西部医学,2018, 30(7):937-942, 947.
|
[15] |
中国抗癌协会.胆囊癌规范化诊治专家共识(2016)[J].临床肝胆病杂志,2017, 33(4):611-620.
|
[16] |
Tatli F, Ozgönül A, Yucel Y, et al. Incidental gallbladder cancer at cholecystectomy[J]. Ann Ital Chir, 2017(6):399-402.
|
[17] |
Kasumova GG, Tabatabaie O, Najarian RM, et al. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy[J]. Ann Surg, 2017, 266(4):625-631.
|
[18] |
Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies[J]. Surg Clin North Am, 2019, 99(2):337-355.
|
[19] |
Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement[J]. HPB, 2015, 17(8):681-690.
|
[20] |
Yi X, Long X, Zai H, et al. Unsuspected gallbladder carcinoma discovered during or after cholecystectomy: focus on appropriate radical re-resection according to the T-stage[J]. Clin Transl Oncol, 2013, 15(8): 652-658.
|
[21] |
Zhou D, Wang J, Quan Z, et al. Improvement in the diagnosis and treatment of T2 gallbladder carcinoma is pivotal to improvement in the overall prognosis for this disease[J]. Biosci Trends, 2019, 13(1): 1-9.
|
[22] |
Sheikh MR, Osman H, Cheek S, et al. T2 gallbladder cancer-aggressive therapy is warranted[J]. Am Surg, 2016, 82(6): 518-521.
|
[23] |
Vega EA, Vinuela E, Okuno M, et al. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors[J]. HPB, 2019, DOI: 10.1016/j.hpb.2018.12.006[Epub ahead of print].
|
[24] |
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location isa strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4): 733-739.
|
[25] |
锁涛,刘厚宝.意外胆囊癌的外科治疗[J/CD].中华肝脏外科手术学电子杂志,2016, 5(4): 206-208.
|
[26] |
Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer-a systematic review[J]. Eur J Surg Oncol, 2019, 45(2):83-91.
|
[27] |
Shukla SK, Singh G, Shahi KS, et al. Staging, treatment, and future approaches of gallbladder carcinoma[J]. J Gastrointest Cancer, 2018, 49(1): 9-15.
|